ALLISON ALMEIDA: Open Payments
NPI 1104368281 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,997 in 110 payments from 14 companies in 2025. Trend: 2023 $1,564 · 2024 $1,771 · 2025 $1,997
Food & beverage: $1,997
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $582 |
| Janssen Biotech, Inc. | 16 | $311 |
| Ardelyx, Inc. | 8 | $182 |
| Aimmune Therapeutics, Inc. | 11 | $145 |
| Phathom Pharmaceuticals, Inc. | 14 | $140 |
| GENZYME CORPORATION | 6 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $129 |
| PFIZER INC. | 4 | $76 |
| Madrigal Pharmaceuticals | 4 | $74 |
| Lilly USA, LLC | 3 | $68 |
Products named: TREMFYA, RINVOQ, IBSRELA, DUPIXENT, LINZESS, ZENPEP, VOQUEZNA, REZDIFFRA.
Industry payments across NC — which companies pay providers there.
